Skip to main content

View full-text article in PMC

. 2023 Aug 30;23:612. doi: 10.1186/s12903-023-03276-5

Table 4.

Baseline characteristics

		Test (n = 17)	Control (n = 17)	P value
Age a	Mean (SD)	55.76 (11.67)	58.35 (11.67)	0.52^a
Gender: n (%)	Males	9 (52.9%)	13 (76.5%)	0.28^b
Gender: n (%)	Females	8 (47.1%)	4 (23.5%)	0.28^b
Diagnosis: n (%)	Laryngeal	5 (29.4%)	6 (35.3%)	0.81^c
	Oral Cavity	9 (52.9%)	9 (52.9%)
	Sinonasal	3 (17.7%)	2 (11.8%)
Radiation therapy: n (%)	Adjuvant	14 (82.3%)	10 (58.8%)	0.26^b
Radiation therapy: n (%)	Definitive	3 (17.7%)	7 (41.2%)	0.26^b
Total radiation dose (GY)	Mean (SD)	64.20 (3.78)	65.18 (4.55)	0.52^a
	Median (IQR)	64.0 (60.0, 66.0)	65.5 (60.0, 70.0)
	Min – Max	60.0–70.0	60.0–70.0
Number of radiation fractions	Mean (SD)	31.87 (2.17)	32.18 (2.65)	0.72^a
	Median (IQR)	32.0 (30.0, 33.0)	32.0 (30.0, 35.0)
	Min – Max	28.0–35.0	28.0–35.0

^a: Independent samples t-test

^b: Fisher exact test

^c: Chi-square test (with Monte Carlo corrected p value)